HOME >> BIOLOGY >> NEWS
Heart and lung transplantation clinical trial results to be announced at ISHLT meeting

More than 2,000 surgeons, scientists, transplant coordinators and nurses from 15 countries will converge April 21-24 for the 24th Annual Meeting and Scientific Session of the International Society for Heart and Lung Transplantation (ISHLT) at the Hilton San Francisco. The meeting will feature advances and emerging technologies in the fields of late stage heart and lung failure, thoracic transplantation, cell transplantation and tissue engineering.

NEW THIS YEAR

For the first time at an ISHLT annual meeting, late-breaking results of high-impact clinical trials will be presented during special plenary sessions. These include:

  • The use of genomic medicine to enhance outcomes in heart transplant recipients
  • Definitive studies of newer distinctive strategies of immunosuppression to decrease rejection rates. Immunosuppression involves the medical suppression of the immune system to prevent organ transplant rejection.
  • The latest information on the impact of novel immunosuppression in tackling coronary artery disease after transplantation using intravascular ultrasound
  • Use of novel drug delivery systems such as inhaled cyclosporine after lung transplantation

The scientific program consists of invited plenary sessions and lectures, in addition to nearly 400 peer-reviewed oral and poster abstract presentations addressing the latest research findings in end-stage thoracic organ failure and transplantation. Topics to be presented include:

  • SARS, West Nile virus and HIV Infectious disease and how they affect thoracic transplantation
  • Latest data from United Network for Organ Sharing (UNOS) and international organ procurement organizations discussing disparities in organ allocation and use
  • Current perspectives on the emerging role of ventricular assist devices (VADs) as destination therapy (as an alternative to transplantation) and their financial implications
  • New ways of using genetic
    '"/>


Contact: Kelly Goff
kellygoff@server63.com
210-378-1980
International Society for Heart and Lung Transplantation
16-Mar-2004


Page: 1 2 3

Related biology news :

1. Heart gene yields insights into evolution, disease risk
2. Heartless worms hold clues to cardiac arrhythmias, sudden death
3. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
4. Heart may heal with help from oxygen-sensitive genes, new study suggests
5. Heart drug might help fight chronic fungal infections
6. Heart disease among some Japanese may be due to sequencing variation inside a gene
7. Heart size and function uncoupled by researchers
8. Heart disease gene linked to prostate cancer
9. Heart-felt stress can be more dangerous to immune system
10. Society for Womens Health Research will be releasing reports related to Heart Month
11. Heart attack in a laboratory dish

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced ... for public health agencies of all sizes. With a focus on tracking symptoms ... find appropriate health care, Mosio helps public health departments automate communications and provide ...
(Date:8/5/2020)... PENSACOLA, Fla. (PRWEB) , ... August 05, 2020 , ... ... to cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly ... a defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to ... a near term focus on Type 2 diabetes and associated comorbidities. , Justin ... therapeutic areas and classes. As Chief Commercial Officer, Justin will lead Better ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... sciences industry, today announced the release of its signature product called Beacon ... Liaisons (MSLs) and other field medical professionals. , Beacon helps MSLs ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/7/2020)... DIEGO (PRWEB) , ... July 06, 2020 , ... R3 ... new program featuring up to 200 million stem cells. Depending on the patient's condition, ... seniors in the US will die having some form of Alzheimers dementia, and the ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a ... Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy with ... , A Safe Space™ enabled business will provide a health performance index system that ...
Breaking Biology Technology:
Cached News: